JOUNCE THERAPEUTICS INC (JNCE) Stock Income Statement
NASDAQ:JNCE - Nasdaq - US4811161011 - Common Stock - Currency: USD
| 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 82.00M | 26.91M | 62.30M | 147.90M | 65.20M | |||
| Operating Expenses | 134.24M | 117.96M | 107.50M | 95.10M | 96.50M | |||
| Research and Development | 103.27M | 88.98M | 78.70M | 67.10M | 70.10M | |||
| Selling, General, and Administrative Expenses | 30.97M | 28.98M | 28.80M | 27.90M | 26.40M | |||
| Operating Income | -52.24M | -91.06M | -45.10M | 52.80M | -31.30M | |||
| Other Income/Expense | 1.46M | 199.00K | 1.30M | 4.10M | 4.00M | |||
| Income Before Taxes | -50.78M | -90.86M | -43.80M | 56.90M | -27.30M | |||
| Income Tax | 135.00K | 15.00K | 0.00 | 0.00 | 0.00 | |||
| Net Income | -50.92M | -90.87M | -43.80M | 56.80M | -27.40M | |||
| EBITDA | -50.16M | -88.23M | -41.70M | 56.70M | -27.50M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.99 | -1.82 | -1.24 | 1.66 | -0.84 | |||
| Non GAAP EPS | -0.99 | -1.84 | -1.47 | 1.63 | -0.83 | |||
| Statistics | ||||||||
| Profit Margin | -62.10% | -337.73% | -70.30% | 38.40% | -42.02% | |||
| Operating Profit Margin | -63.71% | -338.41% | -72.39% | 35.70% | -48.01% | |||
All data in USD